The FDA’s ophthalmology-related news in November included device, drug and feasibility study approvals.
Here are the four most-read FDA news stories published on Healio.com/OSN last month:
1. FDA approves Light Adjustable Lens from RxSight
The Light Adjustable Lens with the Light Delivery Device from RxSight is the first medical device system that can make adjustments to lens power after cataract surgery. Read more here.
2. FDA gives nod to Bausch + Lomb’s once-daily glaucoma drops
Vyzulta (latanoprostene bunod ophthalmic solution, 0.024%) is indicated for the reduction of IOP in
Uncategorized